Gkongensin A, an HSP90β inhibitor, improves hyperlipidemia, hepatic steatosis, and insulin resistance
Cited by 4
Related Papers
Discovery of Imidazopyridine Derivatives as Highly Potent Respiratory Syncytial Virus Fusion Inhibitors
|ACS Medicinal Chemistry Letters|2015|96
<p>Moxibustion Enhances Chemotherapy of Breast Cancer by Affecting Tumor Microenvironment</p>
|Cancer Management and Research|2020|17